Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is 16% above its 5-year average of 86.52%, near the high end of its 5-year range (-9470.25%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 105.51% above its 12-month average of -1814.05%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
-1814.05%
GROSS MARGIN AVG 3Y
76.72%
GROSS MARGIN AVG 5Y
86.52%
GROSS MARGIN AVG 10Y
-18.33%
GROSS MARGIN AVG 15Y
-33.84%
GROSS MARGIN AVG 20Y
-22.47%
CURRENT VS TTM AVG
+105.51%
CURRENT VS 3Y AVG
+30.34%
CURRENT VS 5Y AVG
+15.58%
CURRENT VS 10Y AVG
+645.61%
CURRENT VS 15Y AVG
+395.49%
CURRENT VS 20Y AVG
+545.06%
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
+147.28%
vs the sector median at left
Cardiff Oncology, Inc.
Market Cap
$82.85M
Gross Margin
100.00%
TTM Avg
-1814.05%
3Y Avg
76.72%
5Y Avg
86.52%
Market Cap
$81.86M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$83.76M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-39721.34%
Market Cap
$84.02M
Gross Margin
-736.46%
TTM Avg
-368.23%
3Y Avg
-290.99%
5Y Avg
-1574.61%
Market Cap
$84.54M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$79.24M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | $82.85M | 100.00% | -1814.05% | 76.72% | 86.52% |
| LENSAR Inc (LNSR)vs › | $82.78M | 47.96% | 47.37% | 50.31% | 51.06% |
| MediciNova, Inc. (MNOV)vs › | $82.45M | 7.58% | 3.79% | 26.89% | 34.60% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $81.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $83.76M | 0.00% | 0.00% | 0.00% | -39721.34% |
| Humacyte, Inc. (HUMA)vs › | $84.02M | -736.46% | -368.23% | -290.99% | -1574.61% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nutriband Inc. (NTRB)vs › | $80.78M | 33.14% | 30.24% | 34.48% | 35.28% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.24M | 100.00% | 100.00% | 100.00% | 100.00% |
| Citius Oncology, Inc. (CTOR)vs › | $79.04M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 100.00% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | -9470.25% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | -5742.42% |
| 2024-06-30 | 35.58% |
| 2024-03-31 | 50.24% |
| 2023-12-31 | 33.97% |
| 2023-09-30 | 24.11% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | 100.00% |
| 2022-09-30 | 100.00% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | 100.00% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | 100.00% |
| 2019-09-30 | -5353.64% |
| 2019-06-30 | -1950.97% |
| 2019-03-31 | -1534.94% |
| 2018-12-31 | -765104.54% |
| 2018-09-30 | 69.81% |
| 2018-06-30 | -82.84% |
| 2018-03-31 | -265.85% |
| 2017-12-31 | -107.03% |
| 2017-09-30 | -283.69% |
| 2017-06-30 | -231.54% |
| 2017-03-31 | -548.61% |
| 2016-12-31 | -763.24% |
| 2016-09-30 | -376.42% |
| 2016-06-30 | -296.00% |
| 2016-03-31 | -156.69% |
| 2015-12-31 | -151.90% |
| 2015-09-30 | -202.71% |
| 2015-06-30 | -60.00% |
| 2015-03-31 | -38.95% |
| 2014-12-31 | 73.21% |
| 2014-09-30 | -3379.52% |
| 2014-06-30 | -2411.64% |
| 2014-03-31 | -1200.12% |
| 2013-12-31 | -2615.05% |
| 2013-09-30 | -1992.19% |
| 2013-06-30 | -1826.22% |
| 2013-03-31 | -573.46% |
| 2012-12-31 | -264.48% |
| 2012-09-30 | -141.81% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 0.00% |
| 2006-10-31 | 0.00% |
| 2006-07-31 | 0.00% |
| 2006-04-30 | 0.00% |
| 2005-10-31 | 0.00% |
| 2005-07-31 | 0.00% |
| 2005-04-30 | 0.00% |
| 2005-01-31 | 0.00% |
| 2003-10-31 | 0.00% |
| 2003-07-31 | 0.00% |
| 2003-04-30 | 0.00% |
